FoxScore

Analysis for Olympus

Description & usage

Olympus develops medical technologies with a core focus on endoscopy and minimally invasive solutions for hospitals globally. The company benefits from deep technical specialization and recurring procedural demand. Key factors are procedure growth, product innovation, international penetration, and operating-margin performance.

Basic info

Symbol
7733.T
Type
Stock
Region
Japan
Sector
Health Care
Available history
11.2 years
Last trading day
04/03/2026

Market context

DXY
120.89
US 10Y Real
1.99%
Fed Balance
$6.68T
CPI YoY
2.4%
Fed Rate
3.75%
US 10Y
4.35%
VIX
24.54
HY OAS
3.17%
Brent
$121.88
Core CPI
2.5%
US 2Y
3.84%
ISM PMI

Score overview

The overall score combines Performance, Stability and Trend into one comparable value.

Analysis summary

Technical picture

Overall, the technical picture is still weak and under pressure. Performance, stability and trend sit in a fairly similar range, at 23, 25 and 18 points. The stronger signal still comes from the longer horizon rather than the latest few quarters.

Even in this weaker setup, there is at least one stabilizing piece. The current drawdown sits around 51.2 %, so the picture is weak, but not completely unanchored.

The clearest drag is that price is still below important moving averages. It sits at -2.6 % versus SMA50 and -14.4 % versus SMA200, which points to ongoing technical pressure.

The next key change would be a recovery back above the main moving averages. That would suggest the technical pressure is easing rather than merely slowing.

Current market backdrop

The backdrop is improving on inflation, but not yet on financing conditions. Price pressure is cooling, yet rates still remain high enough to matter.

US 10-year yields remain elevated at 4.35%.

Inflation is cooling, with headline and core readings around 2.4% and 2.5%.

US inflation-adjusted 10-year yields are still high at 1.99%.

In plain language, the inflation trend is moving in a better direction, but financing conditions are not easy yet. That often means the macro picture improves faster than policy relief arrives.

The ISM business activity gauge are currently unavailable or too stale to use, so this is a narrower macro read than usual.

What that means for this asset

For stocks, broad risk appetite matters because it shapes how willing investors are to pay for cyclical exposure or future growth expectations.

At the moment, the macro environment and the chart are leaning the same cautious way. The backdrop is not offering much help to a setup that is already weak.

In plain terms, this is a weak setup with little macro help, so the current reading deserves caution rather than enthusiasm.

Historical evaluation and qualitative market context only, not investment advice.

Price chart

Use the chart to read recent price behavior before drilling into metrics.

Show chart
If you continue, the chart will be loaded from TradingView. Technical data such as your IP address may be transferred to TradingView.

Explore rankings

Open the ranking view you need.

  1. Asset types

    Open rankings by asset type.

  2. Scores

    Open the four score rankings directly and see how the scores are explained.

  3. Metrics

    Open rankings by individual metrics and see what each metric means.

  4. Countries

    Open country rankings and compare how markets perform.

Data snapshot

Validated
Snapshot as of
Apr 03, 2026
Last trading day
Apr 03, 2026
Snapshot status
Validated
Data quality
Passed

Freshness, data quality, and exclusions stay visible. Unavailable values and insufficient history are never treated as valid data.